Dr. Ajay K. Nangia is a Professor of Urology at the University of Kansas Medical Center. Dr. Nangia received his medical degree from St. Thomas and Guy's Hospital Medical School in London, U.K. He completed 2 years of research at Yale University prior to residency. He completed his Urology residency at the University of Pittsburgh Medical Center and a Male Infertility and Microsurgery fellowship at the Cleveland Clinic Foundation in Cleveland, Ohio. Dr. Nangia was in the 2010 Leadership Class for the American Urological Association; President of the Society of Male Reproduction and Urology and on the Residency Education Committee of the American Society of Reproductive Medicine. He is a member of the American College of Surgeons. He is past Chair of the Ethics Committee of the American Society of Andrology, and Past-President of the Society for the Study of Male Reproduction (a branch of the American Urological Association). He is also a liaison with the CDC (Center for Disease Control) for male reproduction. He has written several peer-reviewed journal articles in the field of urology including male infertility, vasectomy reversal microsurgery, vasectomy, and a member of the Best Practice Statement for Male Infertility and also Azoospermia by the American Urological Association. He is a member of the American Urological Associations Men's Health Initiative which is developing screening recommendations for men of all ages. He is on the American Board of Urology written exam committee. He reviews for a number of urology and fertility journals and has lectured internationally, nationally and regionally. He is the Clinical Director of Andrology at the University of Kansas Medical Center and President of the Kansas Urological Society. Dr. Nangia's special interests in the field of urology are micro-surgical reconstruction including vasectomy reversal, male infertility, vasectomy/male contraception and male sexual/reproductive dysfunction,hypogonadism and is actively involved with research in male contraception, as well as the study of vitamin D in sperm/testicular physiology. He is involved with on-going research in the development of a non-hormonal reversible male contraception that is very promising and may go into clinical trials in the next fe years.